173 related articles for article (PubMed ID: 34107577)
1. [Application of anti-HCV and HCV RNA detection in intravenous drug users].
Xu B; Chen B; Ma ZH; Ren YN; Ma JQ; Pei LJ; Xing WW
Zhonghua Gan Zang Bing Za Zhi; 2021 May; 29(5):415-420. PubMed ID: 34107577
[No Abstract] [Full Text] [Related]
2. Indeterminate RIBA results were associated with the absence of hepatitis C virus RNA (HCV-RNA) in blood donors.
Pereira FM; Zarife MA; Reis EA; G Reis M
Rev Soc Bras Med Trop; 2014; 47(1):12-7. PubMed ID: 24603731
[TBL] [Abstract][Full Text] [Related]
3. Characterization of differential antibody production against hepatitis C virus in different HCV infection status.
Rafik M; Bakr S; Soliman D; Mohammed N; Ragab D; ElHady WA; Samir N
Virol J; 2016 Jun; 13():116. PubMed ID: 27357382
[TBL] [Abstract][Full Text] [Related]
4. Detection of hepatitis C virus infection with recombinant immunoblot assay, synthetic immunoblot assay, and polymerase chain reaction.
Chaudhary RK; Andonov A; MacLean C
J Clin Lab Anal; 1993; 7(3):164-7. PubMed ID: 7685380
[TBL] [Abstract][Full Text] [Related]
5. Performance Evaluation of Protein Chip Assay for Rapid Diagnosis of Hepatitis C Virus Infection in Injection Drug Abusers.
Dai Z; Shu X; Li G; Xi W
Clin Lab; 2018 Apr; 64(4):527-534. PubMed ID: 29739068
[TBL] [Abstract][Full Text] [Related]
6. Application of a new enzyme-linked immunosorbent assay for detection of total hepatitis C virus core antigen in blood donors.
Cano H; Candela MJ; Lozano ML; Vicente V
Transfus Med; 2003 Oct; 13(5):259-66. PubMed ID: 14617336
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus RNA in blood donor sera detected by the polymerase chain reaction: comparison with supplementary hepatitis C antibody assays.
Widell A; Månsson AS; Sundström G; Hansson BG; Nordenfelt E
J Med Virol; 1991 Dec; 35(4):253-8. PubMed ID: 1724983
[TBL] [Abstract][Full Text] [Related]
8. A comparison between one first generation and three second generation anti-HCV ELISAs: an investigation in high- and low-risk subjects in correlation with recombinant immunoblot assay and polymerase chain reaction.
Bååth L; Widell A; Nordenfelt E
J Virol Methods; 1992 Dec; 40(3):287-96. PubMed ID: 1282130
[TBL] [Abstract][Full Text] [Related]
9. Detection of hepatitis C virus (HCV) RNA by PCR related to HCV antibodies in serum and liver histology in Swedish blood donors.
Yun ZB; Lindh G; Weiland O; Johansson B; Sönnerborg A
J Med Virol; 1993 Jan; 39(1):57-61. PubMed ID: 7678638
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of hepatitis C virus infection by ELISA, RIBA and RT-PCR: a comparative evaluation.
Mohan KV; Murugavel KG; Rajanikanth ; Mathews S; Raghuram K; Rajasambandam P; Murali A; Srinivas U; Mathiazhagan ; Palaniswamy KR; Panda SK; Thyagarajan SP
Indian J Gastroenterol; 1999; 18(2):73-5. PubMed ID: 10319537
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of antibodies to hepatitis C virus in populations at low and high risk for sexually transmitted diseases in Rio de Janeiro.
Edelenyi-Pinto M; Carvalho AP; Nogueira C; Ferreira Júnior O; Schechter M
Mem Inst Oswaldo Cruz; 1993; 88(2):305-7. PubMed ID: 7509022
[TBL] [Abstract][Full Text] [Related]
12. Increased detection of antibody to hepatitis C virus in renal transplant patients by third-generation assays.
Soffredini R; Rumi M; Lampertico P; Aroldi A; Tarantino A; Ponticelli C; Colombo M
Am J Kidney Dis; 1996 Sep; 28(3):437-40. PubMed ID: 8804244
[TBL] [Abstract][Full Text] [Related]
13. Performance of hepatitis C virus (HCV) antibody test systems in relation to HCV-RNA detection in the diagnosis of HCV infection.
Krarup HB; Jacobsen SE; Varming K; Drewes AM; Madsen PH
Dan Med Bull; 1998 Feb; 45(1):89-91. PubMed ID: 9504268
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology, serological markers, and hepatic disease of anti-HCV ELISA-2-positive blood donors.
Salmerón FJ; Palacios A; Pérez-Ruiz M; Torres C; Oyonarte S; Fernández-Montoya A; Ruiz-Extremera A
Dig Dis Sci; 1996 Oct; 41(10):1933-8. PubMed ID: 8888703
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus (HCV) infection in haemodialysed patients: HCV-RNA and anti-HCV antibodies (third-generation assays).
Couroucé AM; Bouchardeau F; Chauveau P; Le Marrec N; Girault A; Zins B; Naret C; Poignet JL
Nephrol Dial Transplant; 1995; 10(2):234-9. PubMed ID: 7538650
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the available anti-HCV antibody detection tests and RT-PCR assay in the diagnosis of hepatitis C virus infection.
Tashkandy MA; Khodari YA; Ibrahim AM; Dhafar KO; Gazzaz ZJ; Azab BA
Saudi J Kidney Dis Transpl; 2007 Nov; 18(4):523-31. PubMed ID: 17951937
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of hepatitis C virus in Brazilian blood donors using a reverse transcriptase nested polymerase chain reaction: comparison with enzyme immunoassay and recombinant protein immunoblot assay.
Gonçales NS; Costa FF; Vassallo J; Gonçales FL
Rev Inst Med Trop Sao Paulo; 2000; 42(5):263-7. PubMed ID: 11058936
[TBL] [Abstract][Full Text] [Related]
18. Detection of anti-hepatitis C virus antibodies in patients undergoing dialysis by utilizing a hepatitis C virus 3.0 assay: correlation with hepatitis C virus RNA.
de Medina M; Hill M; Sullivan HO; Leclerq B; Pennell JP; Jeffers L; Reddy KR; Schiff ER; Perez GO
J Lab Clin Med; 1998 Jul; 132(1):73-5. PubMed ID: 9665375
[TBL] [Abstract][Full Text] [Related]
19. Supplementary anti-hepatitis C virus (HCV) testing with 2nd and 3rd generation recombinant immunoblot assay and matrix applied to enzyme immunoassay positive sera and comparison with HCV-RNA detection.
Engel PM; Dennin RH
Zentralbl Bakteriol; 1998 Oct; 288(2):267-75. PubMed ID: 9809407
[TBL] [Abstract][Full Text] [Related]
20. The Role of the Signal-to-Cutoff Ratio in Automated Anti-HCV Chemiluminescent Immunoassays by Referring to the Nucleic Acid Amplification Test and the Recombinant Immunoblot Assay.
Choi MS; Lee K; Hong YJ; Song EY; Kim DS; Song J
Ann Lab Med; 2018 Sep; 38(5):466-472. PubMed ID: 29797818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
